Pharmaceutical Immunotoxicity
Pharmaceutical Immunotoxicity is an academic concept referring to the adverse effects of pharmaceutical agents on the immune system of aquatic organisms, distinguished from other forms of immunotoxicity by its specificity to bioactive compounds introduced into aquatic environments through human or veterinary medical use.
52
Publications
1.5K
Citations
192
Authors
90
Institutions
Publications per year
2017–2026
2
52
1–5 of 52
192
United States Food and Drug Administration, United States
4 publications · 65 citations
4
h-index
National Institute for Public Health and the Environment, Netherlands
4 publications · 96 citations
4
h-index
3
h-index
3
h-index
3
h-index
1–5 of 192
90
National Institute for Public Health and the Environment
De Bilt, The Netherlands
6 h-index
25 publications
659 citations
United States Food and Drug Administration
Silver Spring, United States
4 h-index
5 publications
89 citations
Environmental Protection Agency
Washington, United States
3 h-index
3 publications
75 citations
Pfizer (United States)
New York, United States
3 h-index
9 publications
202 citations
National Institute of Food and Drug Safety Evaluation
Cheongju-si, South Korea
3 h-index
16 publications
467 citations
Ministry of Food and Drug Safety
Cheongju-si, South Korea
3 h-index
16 publications
467 citations

Research Triangle Park Foundation
Durham, United States
3 h-index
3 publications
75 citations
Sanofi (United States)
Bridgewater, United States
3 h-index
4 publications
119 citations
1–8 of 90
7 publications · 186 citations
7
h-index
4 publications · 74 citations
4
h-index
3 publications · 55 citations
3
h-index
3 publications · 178 citations
3
h-index
Repository · 3 publications · 58 citations
3
h-index
1–5